How COVID-19
will change the management of other respiratory viral infections
Intensive
Care Medicine: 11
August 2021
Started with a local outbreak of pneumonia in Wuhan, China,
coronavirus disease-19 (COVID-19) has spread globally over a short time, to
become one of the largest known pandemic in human history. In parallel, and
within less than a year and a half, there have been great advancements in
understanding the pathophysiology, management, and prevention of COVID-19. The
speed of progress has far exceeded what has been made in many other diseases,
including other severe respiratory viral infections (RVIs). This progress was
driven largely by the pressing urgency created by the unprecedented global
pandemic. However, at the same time, many advancements would not have been
possible without the coordinated research response; a response that has built
on knowledge and networks already present.
While we are still in the midst of the COVID-19 pandemic,
and there is much to learn about this disease, the experience from COVID-19
should transform the approach to addressing future research on RVIs. There are
many biologic similarities and differences between COVID-19 and other RVIs,
which translate to similarities and differences in management. Here, we focus
on selected lessons learned in COVID-19 management and how they may be relevant
for research in other RVIs (Fig. 1;
Table S1)…
No comments:
Post a Comment